The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cells

European Journal of Immunology

Volumn 41, Issue 8, 2011, Pages 2185-2196

  Henning, Petra ^a   Gustafsson, Tobias ^a   Flach, Carl Fredrik ^a   Hua, Yeu Jiann ^a   Strömbeck, Anna ^a   Holmgren, Jan ^a   Lindholm, Leif ^b   Yrlid, Ulf ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Got A Gene AB ^*  (Sweden)

Author keywords

Adenovirus; DCs; Mucosa; Vaccine

Indexed keywords

ADENOVIRUS VECTOR; ANTIBODY; ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; OVALBUMIN;

ADAPTIVE IMMUNITY; ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VAGINA; VIRAL GENE DELIVERY SYSTEM;

ADAPTIVE IMMUNITY; ADENOVIRIDAE; ANIMALS; ANTIGENS; CELL LINE; CELL LINE, TUMOR; CROSS-PRIMING; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

EID: 79960743494     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041009     Document Type: Article

References (43)

1. Russell, K. L., Hawksworth, A. W., Ryan, M. A., Strickler, J., Irvine, M., Hansen, C. J., Gray, G. C. and Gaydos, J. C., Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine 2006. 24: 2835-2842.
2. Patel, A., Zhang, Y., Croyle, M., Tran, K., Gray, M., Strong, J., Feldmann, H. et al., Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice. J. Infect. Dis. 2007. 196: S413-S420.
3. Santosuosso, M., Zhang, X., McCormick, S., Wang, J., Hitt, M. and Xing, Z., Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol. 2005. 174: 7986-7994.
4. Wang, J., Thorson, L., Stokes, R. W., Santosuosso, M., Huygen, K., Zganiacz, A., Hitt, M. and Xing, Z., Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol. 2004. 173: 6357-6365.
5. Xu, Q., Pichichero, M. E., Simpson, L. L., Elias, M., Smith, L. A. and Zeng, M., An adenoviral vector-based mucosal vaccine is effective in protection against botulism. Gene Ther. 2009. 16: 367-375.
6. Yu, J. R., Kim, S., Lee, J. B. and Chang, J., Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection. J. Virol. 2008. 82: 2350-2357.
7. Zhu, Q., Thomson, C. W., Rosenthal, K. L., McDermott, M. R., Collins, S. M. and Gauldie, J., Immunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infection. Mucosal. Immunol. 2008. 1: 78-88.
8. HIV vaccine failure prompts Merck to halt trial. Nature 2007. 449, 390.
9. + T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 2008. 181: 4188-4198.
10. Neutra, M. R. and Kozlowski, P. A., Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 2006. 6: 148-158.
11. Van Kampen, K. R., Shi, Z., Gao, P., Zhang, J., Foster, K. W., Chen, D. T., Marks, D. et al., Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 2005. 23: 1029-1036.
12. Arimoto, Y., Nagata, H., Isegawa, N., Kumahara, K., Isoyama, K., Konno, A. and Shirasawa, H., In vivo expression of adenovirus-mediated lacZ gene in murine nasal mucosa. Acta Otolaryngol. 2002. 122: 627-633.
13. Damjanovic, D., Zhang, X., Mu, J., Fe Medina, M. and Xing, Z., Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector. Genet Vaccines Ther. 2008. 6: 5.
14. Herrera, O. B., Brett, S. and Lechler, R. I., Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design. Vaccine 2002. 21: 231-242.
15. Diebold, S. S., Cotten, M., Koch, N. and Zenke, M., MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Gene Ther. 2001. 8: 487-493.
16. Holst, P. J., Sorensen, M. R., Mandrup Jensen, C. M., Orskov, C., Thomsen, A. R. and Christensen, J. P., MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines. J. Immunol. 2008. 180: 3339-3346.
17. Jung, S., Unutmaz, D., Wong, P., Sano, G., De los Santos, K., Sparwasser, T., Wu, S. et al., In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002. 17: 211-220.
18. Probst, H. C. and van den Broek, M., Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J. Immunol. 2005. 174: 3920-3924.
19. + T cells and generation of specific antibodies following mucosal immunization. J. Immunol. 2009. 183: 5032-5041.
20. Hagymasi, A. T., Slaiby, A. M., Mihalyo, M. A., Qui, H. Z., Zammit, D. J., Lefrancois, L. and Adler, A. J., Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells. J. Immunol. 2007. 179: 1524-1531.
21. +, T cells by plasmacytoid dendritic cells. J. Exp. Med. 2007. 204: 1923-1933.
22. Zammit, D. J., Cauley, L. S., Pham, Q. M. and Lefrancois, L., Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 2005. 22: 561-570.
23. Holt, P. G., Haining, S., Nelson, D. J. and Sedgwick, J. D., Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 1994. 153: 256-261.
24. Rawlins, E. L. and Hogan, B. L., Epithelial stem cells of the lung: privileged few or opportunities for many? Development 2006. 133: 2455-2465.
25. Gallichan, W. S. and Rosenthal, K. L., Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 1995. 13: 1589-1595.
26. Prasad, S. A., Norbury, C. C., Chen, W., Bennink, J. R. and Yewdell, J. W., Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells. J. Immunol. 2001. 166: 4809-4812.
27. Shen, L. and Rock, K. L., Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl. Acad. Sci. USA 2004. 101: 3035-3040.
28. Bevan, M. J., Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 2004. 4: 595-602.
29. + T cell help. J. Exp. Med. 1997. 186: 65-70.
30. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. and Heath, W. R., Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998. 393: 478-480.
31. Ridge, J. P., Di Rosa, F. and Matzinger, P., A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998. 393: 474-478.
32. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R. and Melief, C. J., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998. 393: 480-483.
33. Buller, R. M., Holmes, K. L., Hugin, A., Frederickson, T. N. and Morse H. C., 3rd, Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 1987. 328: 77-79.
34. Chen, J., Hsu, H. C., Zajac, A. J., Wu, Q., Yang, P., Xu, X., McPherson, S. A. et al., In vivo analysis of adenovirus-specific cytotoxic T lymphocyte response in mice deficient in CD28, fas ligand, and perforin. Hum. Gene Ther. 2006. 17: 669-682.
35. + dendritic cells in the generation of cytotoxic T cells. Proc. Natl. Acad. Sci. USA 2010. 107: 216-221.
36. Probst, H. C., Tschannen, K., Odermatt, B., Schwendener, R., Zinkernagel, R. M. and Van Den Broek, M., Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin. Exp. Immunol. 2005. 141: 398-404.
37. + T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J. Immunol. 2010. 185: 1513-1521.
38. + T-cell response elicited by recombinant adenovirus vaccines. Mol. Ther. 2007. 15: 997-1006.
39. Boyle, J. S., Koniaras, C. and Lew, A. M., Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol. 1997. 9: 1897-1906.
40. Morel, P. A., Falkner, D., Plowey, J., Larregina, A. T. and Falo, L. D., DNA immunisation: altering the cellular localisation of expressed protein and the immunisation route allows manipulation of the immune response. Vaccine 2004. 22: 447-456.
41. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W. and Vogelstein, B., A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 1998. 95: 2509-2514.
42. Robertson, J. M., Jensen, P. E. and Evavold, B. D., DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J. Immunol. 2000. 164: 4706-4712.
43. Hogquist, K. A., Tomlinson, A. J., Kieper, W. C., McGargill, M. A., Hart, M. C., Naylor, S. and Jameson, S. C., Identification of a naturally occurring ligand for thymic positive selection. Immunity 1997. 6: 389-399.